ERICA EDLUND: Open Payments
NPI 1295104255 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,167 in 137 payments from 16 companies in 2025. Trend: 2023 $4,985 · 2024 $3,994 · 2025 $3,167
Food & beverage: $3,122Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $822 |
| UCB, Inc. | 25 | $469 |
| Novartis Pharmaceuticals Corporation | 14 | $318 |
| AstraZeneca Pharmaceuticals LP | 10 | $282 |
| GlaxoSmithKline, LLC. | 8 | $257 |
| Amgen Inc. | 11 | $249 |
| Janssen Biotech, Inc. | 14 | $218 |
| PFIZER INC. | 10 | $205 |
| ANI Pharmaceuticals, Inc. | 6 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
Products named: Bimzelx, RINVOQ, SKYRIZI, COSENTYX, SAPHNELO, BENLYSTA, TREMFYA, XELJANZ.
Industry payments across FL — which companies pay providers there.
